Neurology: Safety and Immunologic Effects of High- Vs Low-Dose Cholecalciferol in Multiple Sclerosis is organized by American Academy of Neurology (AAN) and will be held during Jan 26, 2016 - Jan 26, 2019.
The target audience for this medical event is Physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Upon completion of the article by Sotirchos et al, the participant should be able to:
• Discuss adverse effects of high- vs low-dose cholecalciferol supplementation in multiple sclerosis (MS) seen during this study
• Describe the effect of vitamin D supplementation on the proportions of CD4+ T cell subsets
• State the effect of vitamin D supplementation on relapse rate
Additional details will be posted as soon as they are available.
Neurology, Immunology and Microbiology